Compare DERM & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | SATL |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.6M | 211.3M |
| IPO Year | 2021 | N/A |
| Metric | DERM | SATL |
|---|---|---|
| Price | $7.92 | $2.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | 138.1K | ★ 3.7M |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $59,399,000.00 | $14,684,000.00 |
| Revenue This Year | $18.34 | N/A |
| Revenue Next Year | $54.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $3.54 | $1.26 |
| 52 Week High | $9.40 | $5.12 |
| Indicator | DERM | SATL |
|---|---|---|
| Relative Strength Index (RSI) | 51.83 | 52.94 |
| Support Level | $7.70 | $1.95 |
| Resistance Level | $8.23 | $2.25 |
| Average True Range (ATR) | 0.34 | 0.20 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 46.31 | 53.33 |
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.